Insider buying last 90 days
No open-market insider purchases were filed for STE in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
STERIS raised its fiscal 2027 adjusted EPS guidance to $11.35-$11.55 after second-quarter results showed adjusted EPS rising 19% to $2.94, helped by a $20 million tariff refund and strong Life Sciences equipment shipments, even as the sterilization business started slower. KeyCorp raised its price target on the stock to $284.00 from $269.00, maintaining an "overweight" rating. The company also filed a Form 424B5 and a Form S-3ASR, along with a mixed shelf offering covering debt securities, ordinary shares, preferred shares, warrants and units.
STE closed at $256.94, up 1.8%, sitting above both its 50-day average of $221.04 and 200-day average of $224.22. The stock's one-month return stands at 19.8%, with a six-month return of 27.3%, though the one-year return is -1.2%. The GekkoIndex reads 40.8, placing the stock in the Distribution zone, down 9.4 over the last five readings. Price sits just 0.6% above Gekko Fair Value of $255.40.
The next earnings date falls on 3 February 2027, 80 days away, placing it outside a typical 20-trading-day holding window. Over the last 90 days, Congress recorded 1 buy and 0 sells in the stock. Analyst coverage from 3 firms shows 3 buy ratings and a consensus target of $260.71, implying 1.5% upside. Seasonality data over 5 years shows the next 20 trading days from this point averaging -0.5%, with gains in 1 of those years, a pattern worth noting given the stock's typical 20-day move of 4.4%.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
STERIS plc (Ireland) scores 2 supportive, 3 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive3 mixed1 headwind
Averages disagree
Close $264.32 sits between the 50-day ($223.27) and 200-day ($224.13) averages, or the averages disagree.
See the chart47, Neutral
Reading 47 is in the Neutral zone.
See the GekkoIndex5.5% above
Price is 5.5% above Gekko Fair Value (more than 5% above).
See fair valueLeans bullish
Last 90 days: Congress 1 buy / 0 sales.
See smart moneyReports in 80 days
Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.
See earnings+2.5% on average
From this point in the calendar, the next 20 trading days averaged +2.5% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
STERIS plc (Ireland) closed at $264.32 on Nov 13, 2026, −1.4% over the past year, inside a 52-week range of $195.14 to $269.44.
Use the left and right arrow keys to read daily values.
Put STE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
STERIS plc focuses on keeping medical and laboratory settings free of contamination, offering goods and services tied to infection control across the United States, Ireland, and other markets. Its offerings span cleaning chemicals, products that confirm sterility, systems for reprocessing endoscopes automatically, and equipment such as surgical tables and lighting, along with tools that connect devices within a facility.
Work at the company is divided into three areas: Healthcare, Applied Sterilization Technologies, and Life Sciences. On top of selling equipment, STERIS handles upkeep of machines, repairs instruments, and sterilizes items under contract for firms that make medical devices and pharmaceutical products.
The company is incorporated in Ireland, and investors can trade its stock on the NYSE, where it carries the ticker STE.
STERIS plc (Ireland)’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 47, in the Neutral zone, up 6.4 points over five sessions.
Up 6.4 points over five sessions, from the Distribution zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 37 | +0.3% | +7.0% | ||
| Accumulation | 263 | +0.2% | +1.2% | ||
| Neutral (current zone) | 371 | +0.2% | −0.7% | ||
| Distribution | 30 | −1.7% | −2.9% | ||
| Selling | 1 | Too few readings yet | |||
Average STE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
STERIS plc (Ireland) trades 5.5% above Gekko Fair Value of $250.51, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what STERIS plc (Ireland) shares are worth, recalculated every trading day.
$250.51
Gekko Fair Value, Nov 14, 2026
5.5% Overvalued
At the end of Aug 2026 the price was 7.3% below the estimate.
No open-market insider purchases were filed for STERIS plc (Ireland), and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for STE in the last 90 days.
From Form 4 filings, dated to when each was filed.
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 11 |
From congressional disclosures, which report amounts as ranges.
STERIS plc (Ireland) has been buying back its own shares.
From company filings.
STERIS plc (Ireland) reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 5 of its last 8 reports.
Feb 3, 2027
80 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $2.59 est $2.49 | $1.50B est $1.49B | −0.5% |
| May 11, 2026 | $2.83 est $2.85 | $1.59B est $1.59B | +1.6% |
| Feb 4, 2026 | $2.53 est $2.53 | $1.50B est $1.48B | −6.8% |
| Nov 5, 2025 | $2.47 est $2.35 | $1.46B est $1.43B | +7.5% |
| Aug 6, 2025 | $2.34 est $2.26 | $1.39B est $1.36B | +5.5% |
| May 14, 2025 | $2.74 est $2.60 | $1.48B est $1.47B | +6.8% |
| Feb 5, 2025 | $2.32 est $2.32 | $1.37B est $1.38B | +2.8% |
| Nov 6, 2024 | $2.14 est $2.13 | $1.33B est $1.33B | −5.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for STERIS plc (Ireland) is $270.71, +2.4% from the last close, from 4 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 4 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 13 | Jefferies | $305 | +15.4% |
| Nov 6 | KeyBanc | $284 | +7.4% |
| Nov 6 | UBS | $290 | +9.7% |
| Nov 5 | Piper Sandler | $275 | +4.0% |
| Aug 17 | KeyBanc | $269 | +1.8% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, STERIS plc (Ireland) averaged +2.5% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | 0.0% | 2 of 5 |
| Next 10 trading days | −0.8% | 2 of 5 |
| Next 15 trading days | +0.7% | 2 of 5 |
| Next 20 trading days | +2.5% | 2 of 5 |
| Next 30 trading days | +2.6% | 3 of 5 |
For scale, STE’s typical 20-trading-day move in either direction is about 4.4%.
STERIS plc (Ireland)’s market cap is $25.67B, with a P/E ratio of 30.4 and revenue of $6.17B over the last twelve months.
Coverage of STERIS plc (Ireland) this week reads positive: 8 positive, 7 neutral and 0 negative headlines.
STERIS plc (Ireland)’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 15.0% above |
| ABTAbbott Laboratories | Neutral | 10.5% below |
| DHRDanaher | Neutral | 4.7% above |
| ISRGIntuitive Surgical | Neutral | 17.5% above |
| MDTMedtronic | Neutral | 14.2% below |
| SYKStryker | Neutral | 0.1% below |
A peer links to its own page where one exists.
STERIS plc (Ireland)’s market cap is $25.67B at the Nov 13, 2026 close of $264.32, with 97.11M shares outstanding. The shares trade on a P/E ratio of 30.4.
The consensus analyst 12-month price target for STERIS plc (Ireland) is $270.71, +2.4% from the last close. Of the 4 firms that rated the stock in the last 90 days, 4 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate STERIS plc (Ireland) is overvalued: the Nov 13, 2026 close of $264.32 is 5.5% above Gekko Fair Value of $250.51. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
STERIS plc (Ireland) is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $2.80 per share on revenue of $1.60B. STERIS plc (Ireland) beat the earnings estimate in 5 of its last 8 reports, moving 4.6% on average across the report.
STERIS plc (Ireland)’s 52-week high is $269.44 and its 52-week low is $195.14; it closed at $264.32 on Nov 13, 2026, −1.4% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 6 items with data read as supportive (smart money and earnings risk), 3 as mixed (trend, gekkoindex and seasonality) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.